Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Giuseppe Lippi, Brandon Michael Henry, Emmanuel J. Favaloro
Abstract
FIGURE 3. Dorsolateral view of Eutropis tammanna sp. nov. (paratype; CMS uncatalogued; ex-CCA 2385), adult female, in life.
Topics & Concepts
SuPARCoronavirus disease 2019 (COVID-19)Urokinase receptorReceptorUrokinaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakPlasminogen activatorInternal medicineGastroenterologyImmunologyChemistryVirologyInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesDermatological and COVID-19 studiesAdipokines, Inflammation, and Metabolic Diseases